Skip to content

Vericel VCEL Price / sales

Price / sales at other companies

Stryker logo
StrykerSYK
-1.1×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
2.1×-0.8×
LeMaitre Vascular logo
LeMaitre VascularLMAT
9.7×+1.3×
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
29.6×+6.5×
Globus Medical logo
Globus MedicalGMED
3.8×-0.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.1×+1.6×

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on the most recent quarter.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's price / sales?
Vericel (VCEL) reported price / sales of 5.6× in Q1 2026.
How has Vericel's price / sales changed year-over-year?
Vericel's price / sales decreased by 40.2% year-over-year, from 9.4× to 5.6×.
What is the long-term trend for Vericel's price / sales?
Over 5 years (2020 to 2025), Vericel's price / sales has grown at a -10.8% compound annual growth rate (CAGR), from 11.6× to 6.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.